Danish Pharmacovigilance Update, April 2015
08 May 2015
The April issue of Danish Pharmacovigilance Update with news from the EU, the DHMA and short news:
News from the EU
- High-dose ibuprofen/dexibuprofen may cause small increased cardiovascular risk, page 2
- EU recommends further measures to minimise risk of osteonecrosis of the jaw with zoledronic acid and denosumab, page 3
- EU's list of recommendations on safety signals, page 4
News from the DHMA
- Warfarin Orion must not replace Marevan and Waran, page 5
- Clozapine and reports of deaths, page 6
- Aubagio® under strict monitoring, page 9
- Influenza vaccines and reports of suspected adverse reactions, page 13
Short news
- Most recent Direct Healthcare Professional Communications (DHPCs), page 16
- Danish Health and Medicines Authority's Annual Pharmacovigilance Report 2014, page 16